Analyzing Elevance Health (ELV) and Its Competitors

Elevance Health (NYSE:ELV – Get Free Report) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its peers? We will compare Elevance Health to similar companies based on the strength of its analyst recommendations, dividends, institutional ownership, profitability, valuation, risk and earnings.

Earnings & Valuation

This table compares Elevance Health and its peers revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Elevance Health $199.12 billion $5.66 billion 18.53
Elevance Health Competitors $21.12 billion $301.67 million -1.67

Elevance Health has higher revenue and earnings than its peers. Elevance Health is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a summary of current ratings for Elevance Health and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health 0 7 15 0 2.68
Elevance Health Competitors 1881 7755 13405 834 2.55

Elevance Health presently has a consensus price target of $456.48, indicating a potential upside of 5.06%. As a group, “Healthcare Providers & Services” companies have a potential upside of 15.71%. Given Elevance Health’s peers higher probable upside, analysts clearly believe Elevance Health has less favorable growth aspects than its peers.

Profitability

This table compares Elevance Health and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Elevance Health 2.55% 14.97% 5.31%
Elevance Health Competitors 1.61% -135.40% -1.32%

Insider & Institutional Ownership

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Dividends

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.6%. Elevance Health pays out 29.3% of its earnings in the form of a dividend. As a group, “Healthcare Providers & Services” companies pay a dividend yield of 1.4% and pay out 24.7% of their earnings in the form of a dividend. Elevance Health has increased its dividend for 14 consecutive years.

Volatility & Risk

Elevance Health has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500. Comparatively, Elevance Health’s peers have a beta of 0.98, suggesting that their average share price is 2% less volatile than the S&P 500.

Summary

Elevance Health beats its peers on 10 of the 15 factors compared.

About Elevance Health

(Get Free Report)

Elevance Health, Inc. is a U.S. health benefits and services company. Formerly known as Anthem, Inc., it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans. The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.

Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.